Labcorp (NYSE:LH – Get Free Report) and Ryman Healthcare (OTCMKTS:RYHTY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.
Risk & Volatility
Labcorp has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Ryman Healthcare has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500.
Earnings and Valuation
This table compares Labcorp and Ryman Healthcare”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Labcorp | $13.95 billion | 1.86 | $876.50 million | $11.29 | 27.97 |
| Ryman Healthcare | $502.59 million | 2.47 | -$100.65 million | N/A | N/A |
Labcorp has higher revenue and earnings than Ryman Healthcare.
Profitability
This table compares Labcorp and Ryman Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Labcorp | 6.66% | 16.29% | 7.62% |
| Ryman Healthcare | N/A | N/A | N/A |
Insider & Institutional Ownership
95.9% of Labcorp shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Analyst Ratings
This is a breakdown of current recommendations and price targets for Labcorp and Ryman Healthcare, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Labcorp | 0 | 2 | 8 | 0 | 2.80 |
| Ryman Healthcare | 0 | 0 | 0 | 0 | 0.00 |
Labcorp currently has a consensus target price of $318.67, indicating a potential upside of 0.92%. Given Labcorp’s stronger consensus rating and higher possible upside, equities analysts plainly believe Labcorp is more favorable than Ryman Healthcare.
Summary
Labcorp beats Ryman Healthcare on 11 of the 12 factors compared between the two stocks.
About Labcorp
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
About Ryman Healthcare
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company's villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hair salons, library, dining area, bar, lounges, croquet laws, shops, and movie theatre facilities. The company owns and operates retirement village units and care units. The company was founded in 1984 and is based in Christchurch, New Zealand.
Receive News & Ratings for Labcorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Labcorp and related companies with MarketBeat.com's FREE daily email newsletter.
